Fennec Pharmaceuticals Inc. (TSE:FRX – Get Free Report) shares crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$6.47 and traded as low as C$5.68. Fennec Pharmaceuticals shares last traded at C$5.68, with a volume of 970 shares.
Fennec Pharmaceuticals Stock Up 0.5 %
The company has a fifty day simple moving average of C$6.47 and a 200-day simple moving average of C$8.13. The company has a quick ratio of 10.17, a current ratio of 8.02 and a debt-to-equity ratio of 1,040.68. The firm has a market cap of C$155.40 million, a P/E ratio of 56.80 and a beta of 0.25.
Fennec Pharmaceuticals Company Profile
Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.
Featured Stories
- Five stocks we like better than Fennec Pharmaceuticals
- Airline Stocks – Top Airline Stocks to Buy Now
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Applied Materials Market Capitulates: Now is the Time to Buy
- What Makes a Stock a Good Dividend Stock?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Fennec Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fennec Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
